Literature DB >> 12566462

Regulation of pT alpha gene expression by a dosage of E2A, HEB, and SCL.

Mathieu Tremblay1, Sabine Herblot, Eric Lecuyer, Trang Hoang.   

Abstract

The expression of the pT alpha gene is required for effective selection, proliferation, and survival of beta T-cell receptor (beta TCR)-expressing immature thymocytes. Here, we have identified two phylogenetically conserved E-boxes within the pT alpha enhancer sequence that are required for optimal enhancer activity and for its stage-specific activity in immature T cells. We have shown that the transcription factors E2A and HEB associate with high affinity to these E-boxes. Moreover, we have identified pT alpha as a direct target of E2A-HEB heterodimers in immature thymocytes because they specifically occupy the enhancer in vivo. In these cells, pT alpha mRNA levels are determined by the presence of one or two functional E2A or HEB alleles. Furthermore, E2A/HEB transcriptional activity is repressed by heterodimerization with SCL, a transcription factor that is turned off in differentiating thymocytes exactly at a stage when pT alpha is up-regulated. Taken together, our observations suggest that the dosage of E2A, HEB, and SCL determines pT alpha gene expression in immature T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566462     DOI: 10.1074/jbc.M209870200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.

Authors:  Teresa Palomero; Duncan T Odom; Jennifer O'Neil; Adolfo A Ferrando; Adam Margolin; Donna S Neuberg; Stuart S Winter; Richard S Larson; Wei Li; X Shirley Liu; Richard A Young; A Thomas Look
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

2.  Identification of cyclin D3 as a direct target of E2A using DamID.

Authors:  Siyuan Song; Jonathan Cooperman; Danielle L Letting; Gerd A Blobel; John Kim Choi
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

3.  Stage-specific functions of E-proteins at the β-selection and T-cell receptor checkpoints during thymocyte development.

Authors:  Mary Elizabeth Jones; Yuan Zhuang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

4.  ETO2 coordinates cellular proliferation and differentiation during erythropoiesis.

Authors:  Nicolas Goardon; Julie A Lambert; Patrick Rodriguez; Philippe Nissaire; Sabine Herblot; Pierre Thibault; Dominique Dumenil; John Strouboulis; Paul-Henri Romeo; Trang Hoang
Journal:  EMBO J       Date:  2006-01-12       Impact factor: 11.598

5.  Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.

Authors:  Y Li; C Deng; X Hu; B Patel; X Fu; Y Qiu; M Brand; K Zhao; S Huang
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

Review 6.  E and ID proteins branch out.

Authors:  Barbara L Kee
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

7.  Modelling acute leukemias in mice: clonal evolution and the emergence of leukemic stem cells.

Authors:  Bastien Gerby; Trang Hoang
Journal:  BMC Proc       Date:  2013-04-04

8.  SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability.

Authors:  Y Wang; S Klumpp; H M Amin; H Liang; J Li; Z Estrov; P Zweidler-McKay; S J Brandt; A Agulnick; L Nagarajan
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

9.  Homo-binding character of LMO2 isoforms and their both synergic and antagonistic functions in regulating hematopoietic-related target genes.

Authors:  Wei Sun; Wen-Wen Shen; Shuang Yang; Fen Hu; Yang Gao; Yu-Huan Qiao; Tian-Hui Zhu
Journal:  J Biomed Sci       Date:  2010-03-27       Impact factor: 8.410

Review 10.  Transcription factors and target genes of pre-TCR signaling.

Authors:  Cristina López-Rodríguez; Jose Aramburu; Rosa Berga-Bolaños
Journal:  Cell Mol Life Sci       Date:  2015-02-22       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.